A man who sold land for a controversial, Jared Kushner-backed luxury development in Albania is suspected of money laundering ...

Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...

A growing number of people with stage 4 cancer are experiencing the power of this new medication. “It does provide options ...

Anthropic announced the availability of Claude Science, which optimizes its large language model for use in scientific labs ...

The biotechnology company will use the federal pilot program for its planned $2 billion Saratoga Springs manufacturing campus ...

(NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced an important enrollment ...

Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI's transformative role in drug development on 'Mornings with ...

If you’ve turned on a television in Ohio recently, you’ve likely seen one of Vivek Ramaswamy’s attack ads targeting Amy Acton ...

Somewhere in Ghana today, a young student sits in a classroom under the influence of drugs. Another young person who once dreamed of becoming a doctor, engineer, teacher, entrepreneur, soldier, police ...

Anthropic AI for Science event livestreams today as the company pitches Claude to pharma and biotech leaders. The session ...

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...